Relevance of polymorphic drug oxidation in the use of neuroleptics in schizophrenia.
Tang
S W
SW
D000657:Amoxapine / Q000378:metabolism; D000929:Antidepressive Agents, Tricyclic / Q000378:metabolism; D014150:Antipsychotic Agents / Q000378:metabolism / Q000627:therapeutic use*; D044466:Asian People; D002746:Chlorpromazine / Q000378:metabolism; D003647:Debrisoquin / Q000378:metabolism; D006801:Humans; D010084:Oxidation-Reduction; D010641:Phenotype; D011110:Polymorphism, Genetic; D012559:Schizophrenia / Q000188:drug therapy*; D044465:White People
D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D000657:Amoxapine; D002746:Chlorpromazine; D003647:Debrisoquin